Biological bases for a possible effect of cannabidiol in Parkinson’s disease

Current pharmacotherapy of Parkinson’s disease (PD) is palliative and unable to modify the progression of neurodegeneration. Treatments that can improve patients’ quality of life with fewer side effects are needed, but not yet available. Cannabidiol (CBD), the major non-psychotomimetic constituent o...

全面介紹

Na minha lista:
書目詳細資料
發表在:Braz J Psychiatry
Main Authors: Ferreira-Junior, Nilson C., Campos, Alline C., Guimarães, Francisco S., Del-Bel, Elaine, Zimmermann, Patrícia M. da R., Brum, Liberato, Hallak, Jaime E., Crippa, José A., Zuardi, Antonio W.
格式: Artigo
語言:Inglês
出版: Associação Brasileira de Psiquiatria 2019
主題:
Special Article
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC7115443/
https://ncbi.nlm.nih.gov/pubmed/31314869
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1590/1516-4446-2019-0460
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍